Parkwood LLC lowered its stake in Anthem Inc (NYSE:ANTM) by 51.8% during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 25,715 shares of the company’s stock after selling 27,604 shares during the period. Anthem accounts for about 1.0% of Parkwood LLC’s holdings, making the stock its 26th largest holding. Parkwood LLC’s holdings in Anthem were worth $6,121,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors also recently bought and sold shares of ANTM. CI Global Investments Inc. purchased a new stake in shares of Anthem in the 1st quarter worth approximately $170,362,000. Iridian Asset Management LLC CT purchased a new stake in shares of Anthem in the 2nd quarter worth approximately $163,011,000. BlackRock Inc. grew its stake in shares of Anthem by 2.7% in the 1st quarter. BlackRock Inc. now owns 22,596,529 shares of the company’s stock worth $4,964,457,000 after buying an additional 596,099 shares during the last quarter. Allianz Asset Management GmbH grew its stake in shares of Anthem by 31.5% in the 1st quarter. Allianz Asset Management GmbH now owns 2,108,871 shares of the company’s stock worth $463,319,000 after buying an additional 505,252 shares during the last quarter. Finally, Bessemer Group Inc. grew its stake in shares of Anthem by 1,097.5% in the 2nd quarter. Bessemer Group Inc. now owns 463,480 shares of the company’s stock worth $110,322,000 after buying an additional 424,775 shares during the last quarter. Institutional investors own 86.37% of the company’s stock.
ANTM has been the topic of several recent research reports. Zacks Investment Research downgraded Anthem from a “buy” rating to a “hold” rating in a research note on Tuesday, July 3rd. BMO Capital Markets upgraded Anthem from a “market perform” rating to an “outperform” rating and increased their target price for the company from $275.00 to $290.00 in a research note on Monday, July 9th. Cantor Fitzgerald reiterated a “buy” rating and set a $275.00 target price on shares of Anthem in a research note on Wednesday, April 25th. Morgan Stanley increased their target price on Anthem from $266.00 to $269.00 and gave the company an “equal weight” rating in a research note on Thursday, April 26th. Finally, ValuEngine upgraded Anthem from a “hold” rating to a “buy” rating in a research note on Tuesday, June 26th. Three investment analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company. The company presently has an average rating of “Buy” and a consensus price target of $269.00.
Shares of ANTM opened at $263.95 on Monday. The company has a current ratio of 1.52, a quick ratio of 1.52 and a debt-to-equity ratio of 0.61. Anthem Inc has a 12 month low of $179.40 and a 12 month high of $268.04. The firm has a market cap of $67.60 billion, a price-to-earnings ratio of 21.92, a price-to-earnings-growth ratio of 1.42 and a beta of 0.89.
Anthem (NYSE:ANTM) last issued its earnings results on Wednesday, July 25th. The company reported $4.25 EPS for the quarter, beating the consensus estimate of $4.16 by $0.09. The business had revenue of $22.71 billion for the quarter, compared to the consensus estimate of $22.66 billion. Anthem had a return on equity of 13.28% and a net margin of 4.79%. The company’s revenue was up 2.3% compared to the same quarter last year. During the same period last year, the business posted $3.37 EPS. equities research analysts expect that Anthem Inc will post 15.48 earnings per share for the current year.
The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 25th. Stockholders of record on Monday, September 10th will be issued a dividend of $0.75 per share. The ex-dividend date of this dividend is Friday, September 7th. This represents a $3.00 annualized dividend and a dividend yield of 1.14%. Anthem’s payout ratio is 24.92%.
In other news, Director Julie A. Hill sold 1,000 shares of the stock in a transaction on Friday, May 25th. The stock was sold at an average price of $233.00, for a total transaction of $233,000.00. Following the transaction, the director now directly owns 35,075 shares of the company’s stock, valued at approximately $8,172,475. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director Julie A. Hill sold 248 shares of the stock in a transaction on Thursday, August 16th. The shares were sold at an average price of $267.01, for a total value of $66,218.48. Following the transaction, the director now directly owns 34,827 shares in the company, valued at $9,299,157.27. The disclosure for this sale can be found here. Insiders have sold a total of 20,789 shares of company stock worth $5,119,592 over the last three months. Insiders own 0.31% of the company’s stock.
Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets.
Featured Story: How do investors use RSI to grade stocks?
Want to see what other hedge funds are holding ANTM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Anthem Inc (NYSE:ANTM).
Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.